Navigation Links
SCOLR Pharma, Inc. Reports Third Quarter 2010 Financial Results
Date:11/10/2010

BOTHELL, Wash., Nov. 10, 2010 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE AMEX: DDD) today reported financial results for the three and nine months ended September 30, 2010.Stephen J. Turner, SCOLR Pharma's President and CEO, said, "Our focus for the remainder of the year will be to continue executing the plans for our extended release nutritional supplement and drug delivery businesses, which have both been advanced in the last quarter.

"We believe that our extended release formulations of nutritional products will offer consumers the benefits of these supplements on a continuous basis throughout the day, while also providing retailers an opportunity to provide their customers with greater choice.  Working with the Emerson Group, we have been meeting with national retailers during their fourth quarter 2010 purchase planning cycles to present our nutritional products.  Orders placed by these retailers in late 2010 or early 2011 would be expected to ship in early-mid 2011," Turner added.

Turner continued:  "In the drug delivery business, we appear to be in the final stages of review by the Food and Drug Administration of our Abbreviated New Drug Application for extended release pseudoephedrine.  Additionally, we have nearly completed protocol planning for the actual use label comprehension study for our extended release, 12-hour ibuprofen product.  We expect to engage a services provider in the first quarter of 2011 in preparation for the conduct of that study. Additional revenue, financing or partnership support is required to complete the study, but we believe the Company is well positioned to move forward."

SCOLR Pharma also announced it was recently engaged by RedHill BioPharma, Ltd., to develop and test the manufacturing feasibility of prototype ondansetron tablets incorporating SCOLR's CDT technology. RedHill is an Isr
'/>"/>

SOURCE SCOLR Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
2. SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products
3. SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd.
4. SCOLR Pharma, Inc. Licenses Dietary Supplements
5. SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards
6. SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
7. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
8. SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
9. Reportlinker Adds Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics, 4th edition
10. Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition
11. Horizon Pharma, Inc. Files Registration Statement for Proposed Initial Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Calif. , July 31, 2014 Touro ... it has been selected as the recipient of a ... which will allow the University to increase research and ... about creating state-of-the-art technology for the study of health ... enhance the diverse needs and interests of our students," ...
(Date:7/31/2014)... , July 31, 2014 For its innovative ... California , Art,s-Way Scientific has earned a Modular ... With competition in over 30 categories, MBI,s contest is ... members, which include building manufacturers, dealers, and product and ... excellent example the capability of our team," said ...
(Date:7/31/2014)... VIENNA , July 31, 2014 ... in New York results of AFF008, ... Parkinson,s disease. PD01A is the first therapy against the protein ... The Michael J. Fox Foundation for Parkinson,s Research ... and presented at the press conference on the impact a ...
Breaking Medicine Technology:Touro University California Garners Grant From Long Foundation 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 3Art's Way Scientific Earns Prestigious Modular Building Institute Award 4First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 3First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 4
(Date:8/1/2014)... (HealthDay News) -- Roaming the high Alps more than ... as the "Ice Man" no doubt had a very tough ... not have shielded the Ice Man, nicknamed Otzi, from a ... for atherosclerosis, or "hardening of the arteries," appears to be ... a new study finds. "Our ancestors going back ...
(Date:8/1/2014)... , Parkinson,s disease affects ... activity ceases and the cells die. Researchers at the Max ... supplying D-lactate or glycolate, two products of the gene DJ-1, ... to cultured HeLa cells and to cells of the nematode ... prevented the degeneration of neurons. They also showed that the ...
(Date:8/1/2014)... 01, 2014 The North America Sports Drink ... North America, with analysis and forecast of revenue. The Sports ... around $5,021.9 million in 2012 to $6,243 million by 2018, ... Browse through the TOC of the North America Sports Drink ... provided. This also provides a glimpse of the segmentation in ...
(Date:8/1/2014)... Gerontological Society of America (GSA) ... field of aging has chosen Madonna Harrington ... PhD, of the University of Luxembourg; and Philipp ... The London School of Economics and Political Science ... Innovative Publication Awards. , These distinguished honors recognize ...
(Date:8/1/2014)... According to Forrester Research, more than 90 ... in search of information, and thanks to the launching of ... information and resources on insurance specifically for the state of ... this next step in the growth of our business,” Doug ... - Commercial Insurance Resources office. “We recognize that the web ...
Breaking Medicine News(10 mins):Health News:'Ice Man' Mummy May Have Been at Risk of Heart Disease 2Health News:Potential treatment and prevention of Parkinson's disease 2Health News:North America Sports Drinks Market is Expected to Reach $6,243 Million in 2018 - New Report by MicroMarket Monitor 2Health News:North America Sports Drinks Market is Expected to Reach $6,243 Million in 2018 - New Report by MicroMarket Monitor 3Health News:North America Sports Drinks Market is Expected to Reach $6,243 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Harrington Meyer, Leist, Hessel, Avendano to receive GSA's 2014 Kalish awards 2Health News:DCInsurers Agent Doug King Launches a New Website 2Health News:DCInsurers Agent Doug King Launches a New Website 3
... HealthDay Reporter , TUESDAY, Sept. 13 (HealthDay News) -- ... aortic valve live in fear of sudden death, but a ... complication called aortic dissection. However, these people are at ... or bulge in the wall of the aorta, researchers report. ...
... children with autism spectrum disorder (ASD), routine medical procedures ... difficult. Communication and social interaction deficits and reliance on ... the significant factors to be considered when preparing a ... effort to help families and medical providers make necessary ...
... of Boston,s elderly homeless population is emerging from a ... Hebrew SeniorLife, an affiliate of Harvard Medical School. The ... rates of geriatric syndromes, including functional decline, falls, frailty ... that many of these conditions may be easily treated ...
... a widely prescribed class of drugs used to lower cholesterol, ... in people who,ve had strokes, new research finds. Statins ... caused by blocked blood flow to the brain, to reduce ... raised concerns that statins might also raise the risk of ...
... Health and Sanford-Burnham Medical Research Institute (Sanford-Burnham) have ... laboratory scientists uncovering new approaches for treating cancer ... Basic medical research often struggles to achieve ... into medical practice. The field of translational medicine ...
... that taking the anti-inflammatory drug celecoxib can reduce the ... at the cost of increasing the risk of heart ... Researchers at Winship Cancer Institute of Emory University ... cells into suicide, separately from its known effects. The ...
Cached Medicine News:Health News:Heart Defect Seems to Pose Low Risk of Aorta Tear 2Health News:Autism Speaks launches 'blood draw' tool kit -- practical guidance for parents and providers 2Health News:Autism Speaks launches 'blood draw' tool kit -- practical guidance for parents and providers 3Health News:Institute for Aging Research study finds Boston's elderly homeless sicker than others 2Health News:Statins Don't Raise Risk of Brain Bleeds After Stroke: Study 2Health News:Scripps Health and Sanford-Burnham to collaborate to advance new cancer treatments 2Health News:Separating a cancer prevention drug from heart disease risk 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: